US Bancorp’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-200
Closed -$1K 4308
2021
Q4
$1K Hold
200
﹤0.01% 4074
2021
Q3
$1K Sell
200
-638
-76% -$2.41K ﹤0.01% 4055
2021
Q2
$3K Buy
838
+443
+112% +$1.56K ﹤0.01% 3788
2021
Q1
$2K Buy
395
+195
+98% +$805 ﹤0.01% 3758
2020
Q4
$1K Hold
200
﹤0.01% 3747
2020
Q3
$1K Hold
200
﹤0.01% 3681
2020
Q2
$1K Hold
200
﹤0.01% 3708
2020
Q1
$1K Hold
200
﹤0.01% 3659
2019
Q4
$1K Hold
200
﹤0.01% 3636
2019
Q3
$1K Hold
200
﹤0.01% 3562
2019
Q2
$1K Hold
200
﹤0.01% 3601
2019
Q1
$1K Hold
200
﹤0.01% 3566
2018
Q4
$1K Hold
200
﹤0.01% 3574
2018
Q3
$1K Hold
200
﹤0.01% 3613
2018
Q2
$1K Hold
200
﹤0.01% 3594
2018
Q1
$0 Hold
200
﹤0.01% 3811
2017
Q4
$1K Hold
200
﹤0.01% 3585
2017
Q3
$1K Hold
200
﹤0.01% 3555
2017
Q2
$1K Hold
200
﹤0.01% 3517
2017
Q1
$0 Sell
200
-300
-60% -$579 ﹤0.01% 3751
2016
Q4
$1K Buy
500
+300
+150% +$613 ﹤0.01% 3521
2016
Q3
$1K Hold
200
﹤0.01% 3512
2016
Q2
$0 Buy
+200
New +$552 ﹤0.01% 3796
2015
Q1
Sell
-276
Closed -$3K 3761
2014
Q4
$3K Buy
+276
New +$4.19K ﹤0.01% 3403

Other funds holding BDSI

US Bancorp's BDSI Position: Q1 2022 in Review

US Bancorp sold out of BioDelivery Sciences International, Inc. (BDSI) in Q1 2022, closing a stake of 200 shares — an estimated $1K sold.

US Bancorp first reported a position in BDSI in Q4 2014 and held it in 24 quarters. The position peaked at $3K in Q2 2021. 2 funds tracked by Wall St. Rank hold BDSI as of Q1 2022.

  • US Bancorp reported no remaining BioDelivery Sciences International, Inc. position as of Q1 2022 after selling out during the quarter.
  • US Bancorp sold 200 BioDelivery Sciences International, Inc. shares in Q1 2022, an estimated $1K.
  • US Bancorp first reported a position in BioDelivery Sciences International, Inc. in Q4 2014 and held it in 24 quarters.
  • US Bancorp's BioDelivery Sciences International, Inc. position peaked at $3K in Q2 2021.
  • 2 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q1 2022.

Based on US Bancorp's 13F filing for Q1 2022, filed 11 May 2022.